Differential Expression Analysis for Pathways

PLoS Computational Biology

Volumn 9, Issue 3, 2013, Pages

  Haynes, Winston A ^a,b,c   Higdon, Roger ^a,b,d   Stanberry, Larissa ^a,b,d   Collins, Dwayne ^c   Kolker, Eugene ^a,b,d,e  

^a SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^b Data Enabled Life Sciences Alliance International DELSA Global   (United States)

^c HENDRIX COLLEGE   (United States)

^d Seattle Children's   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; GENE EXPRESSION; GLYCOPROTEINS; PULMONARY DISEASES;

BIOLOGICAL FUNCTIONS; BIOLOGICAL PATHWAYS; EXPRESSION ANALYSIS; EXPRESSION DATA; LIFE-SCIENCES; ORDERS OF MAGNITUDE; PERFORMANCE; POWER; REGULATORY PATTERNS; SCIENCE TECHNOLOGIES;

INTERFERONS;

GAMMA INTERFERON; JANUS KINASE; NOTCH RECEPTOR; STAT PROTEIN;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DATA ANALYSIS; DIFFERENTIAL EXPRESSION ANALYSIS FOR PATHWAY; GENE EXPRESSION PROFILING; GENE SET ENRICHMENT ANALYSIS; GENETIC ALGORITHM; GENETIC ANALYSIS; INTERMETHOD COMPARISON; PROTEIN EXPRESSION; SCORING SYSTEM; SIGNAL TRANSDUCTION; SIGNALLING PATHWAY IMPACT ANALYSIS; SIMULATION; VALIDATION PROCESS;

EID: 84875990816     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1002967     Document Type: Article

References (65)

1. Pennisi E, (2011) Will Computers Crash Genomics? Science 331: 666-668 doi:10.1126/science.331.6018.666.
2. Science Staff (2011) Challenges and Opportunities. Science 331: 692-693 doi:10.1126/science.331.6018.692.
3. Gough NR, Yaffe MB, (2011) Focus Issue: Conquering the Data Mountain. Science Signaling 4: eg2-eg2 doi:10.1126/scisignal.2001871.
4. Kolker E, Stewart E, Ozdemir V, (2012) Opportunities and Challenges for the Life Sciences Community. OMICS: A Journal of Integrative Biology 16: 138-147 doi:10.1089/omi.2011.0152.
5. Ozdemir V, Rosenblatt DS, Warnich L, Srivastava S, Tadmouri GO, et al. (2011) Towards an Ecology of Collective Innovation: Human Variome Project (HVP), Rare Disease Consortium for Autosomal Loci (RaDiCAL) and Data-Enabled Life Sciences Alliance (DELSA). Current Pharmacogenomics and Personalized Medicine 9: 234-251.
6. Edgar R, Domrachev M, Lash AE, (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.
7. Desiere F, Deutsch EW, Nesvizhskii AI, Mallick P, King NL, et al. (2005) Integration with the human genome of peptide sequences obtained by high-throughput mass spectrometry. Genome Biol 6: R9 doi:10.1186/gb-2004-6-1-r9.
8. Vizcaíno JA, Côté R, Reisinger F, Foster JM, Mueller M, et al. (2009) A guide to the Proteomics Identifications Database proteomics data repository. Proteomics 9: 4276-4283 doi:10.1002/pmic.200900402.
9. Sherlock G, Hernandez-Boussard T, Kasarskis A, Binkley G, Matese JC, et al. (2001) The Stanford Microarray Database. Nucleic Acids Res 29: 152-155.
10. Kolker E, Higdon R, Haynes W, Welch D, Broomall W, et al. (2012) MOPED: Model Organism Protein Expression Database. Nucleic Acids Res 40: D1093-1099 doi:10.1093/nar/gkr1177.
11. Thomas PD, Campbell MJ, Kejariwal A, Mi H, Karlak B, et al. (2003) PANTHER: a library of protein families and subfamilies indexed by function. Genome Res 13: 2129-2141 doi:10.1101/gr.772403.
12. Caspi R, Foerster H, Fulcher CA, Kaipa P, Krummenacker M, et al. (2008) The MetaCyc Database of metabolic pathways and enzymes and the BioCyc collection of Pathway/Genome Databases. Nucleic Acids Res 36: D623-631 doi:10.1093/nar/gkm900.
13. Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, et al. (1999) KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 27: 29-34.
14. Joshi-Tope G, Gillespie M, Vastrik I, D'Eustachio P, Schmidt E, et al. (2005) Reactome: a knowledgebase of biological pathways. Nucleic Acids Res 33: D428-432 doi:10.1093/nar/gki072.
15. Mootha VK, Lindgren CM, Eriksson K-F, Subramanian A, Sihag S, et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267-273 doi:10.1038/ng1180.
16. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102: 15545-15550 doi:10.1073/pnas.0506580102.
17. Kim S-Y, Volsky DJ, (2005) PAGE: parametric analysis of gene set enrichment. BMC Bioinformatics 6: 144 doi:10.1186/1471-2105-6-144.
18. Jiang Z, Gentleman R, (2007) Extensions to gene set enrichment. Bioinformatics 23: 306-313 doi:10.1093/bioinformatics/btl599.
19. Cha S, Imielinski MB, Rejtar T, Richardson EA, Thakur D, et al. (2010) In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology. Mol Cell Proteomics 9: 2529-2544 doi:10.1074/mcp.M110.000398.
20. Tian L, Greenberg SA, Kong SW, Altschuler J, Kohane IS, et al. (2005) Discovering statistically significant pathways in expression profiling studies. Proc Natl Acad Sci USA 102: 13544-13549 doi:10.1073/pnas.0506577102.
21. Rahnenführer J, Domingues FS, Maydt J, Lengauer T, (2004) Calculating the Statistical Significance of Changes in Pathway Activity From Gene Expression Data. Statistical Applications in Genetics and Molecular Biology 3Available:http://www.degruyter.com/view/j/sagmb.2004.3.1/sagmb.2004.3.1.1055/sagmb.2004.3.1.1055.xml Accessed 11 December 2012.
22. Goeman JJ, Bühlmann P, (2007) Analyzing gene expression data in terms of gene sets: methodological issues. Bioinformatics 23: 980-987 doi:10.1093/bioinformatics/btm051.
23. Draghici S, Khatri P, Tarca AL, Amin K, Done A, et al. (2007) A systems biology approach for pathway level analysis. Genome Res 17: 1537-1545 doi:10.1101/gr.6202607.
24. Tarca AL, Draghici S, Khatri P, Hassan SS, Mittal P, et al. (2009) A novel signaling pathway impact analysis. Bioinformatics 25: 75-82 doi:10.1093/bioinformatics/btn577.
25. Bankhead A 3rd, Sach I, Ni C, LeMeur N, Kruger M, et al. (2009) Knowledge based identification of essential signaling from genome-scale siRNA experiments. BMC Syst Biol 3: 80 doi:10.1186/1752-0509-3-80.
26. Zhao J, Gupta S, Seielstad M, Liu J, Thalamuthu A, (2011) Pathway-based analysis using reduced gene subsets in genome-wide association studies. BMC Bioinformatics 12: 17 doi:10.1186/1471-2105-12-17.
27. Hung J-H, Whitfield TW, Yang T-H, Hu Z, Weng Z, et al. (2010) Identification of functional modules that correlate with phenotypic difference: the influence of network topology. Genome Biol 11: R23 doi:10.1186/gb-2010-11-2-r23.
28. Thomas R, Gohlke JM, Stopper GF, Parham FM, Portier CJ, (2009) Choosing the right path: enhancement of biologically relevant sets of genes or proteins using pathway structure. Genome Biol 10: R44 doi:10.1186/gb-2009-10-4-r44.
29. Vaske CJ, Benz SC, Sanborn JZ, Earl D, Szeto C, et al. (2010) Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics 26: i237-i245 doi:10.1093/bioinformatics/btq182.
30. Shojaie A, Michailidis G, (2009) Analysis of Gene Sets Based on the Underlying Regulatory Network. Journal of Computational Biology 16: 407-426 doi:10.1089/cmb.2008.0081.
31. Khatri P, Sirota M, Butte AJ, (2012) Ten Years of Pathway Analysis: Current Approaches and Outstanding Challenges. PLoS Computational Biology 8: e1002375 doi:10.1371/journal.pcbi.1002375.
32. Langsrud O, (2005) Rotation tests. Statistics and Computing 15: 53-60 doi:10.1007/s11222-005-4789-5.
33. Wu D, Lim E, Vaillant F, Asselin-Labat M-L, Visvader JE, et al. (2010) ROAST: rotation gene set tests for complex microarray experiments. Bioinformatics 26: 2176-2182 doi:10.1093/bioinformatics/btq401.
34. Dørum G, Snipen L, Solheim M, Saebø S, (2009) Rotation testing in gene set enrichment analysis for small direct comparison experiments. Stat Appl Genet Mol Biol 8: Article34 doi:10.2202/1544-6115.1418.
35. Storey JD, Tibshirani R, (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci USA 100: 9440-9445 doi:10.1073/pnas.1530509100.
36. Khodarev NN, Minn AJ, Efimova EV, Darga TE, Labay E, et al. (2007) Signal transducer and activator of transcription 1 regulates both cytotoxic and prosurvival functions in tumor cells. Cancer Res 67: 9214-9220 doi:10.1158/0008-5472.CAN-07-1019.
37. Khodarev NN, Beckett M, Labay E, Darga T, Roizman B, et al. (2004) STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells. Proc Natl Acad Sci USA 101: 1714-1719 doi:10.1073/pnas.0308102100.
38. Hu X, Ivashkiv LB, (2009) Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune Diseases. Immunity 31: 539-550 doi:10.1016/j.immuni.2009.09.002.
39. Fuke S, Betsuyaku T, Nasuhara Y, Morikawa T, Katoh H, et al. (2004) Chemokines in bronchiolar epithelium in the development of chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 31: 405-412 doi:10.1165/rcmb.2004-0131OC.
40. Kolker E, Higdon R, Welch D, Bauman A, Stewart E, et al. (2011) SPIRE: Systematic protein investigative research environment. J Proteomics 75: 122-126 doi:10.1016/j.jprot.2011.05.009.
41. R Development Core Team (n.d.) R: A language and environment for statistical computing. Vienna (Austria): R Foundation for Statistical Computing. Available:http://www.R-project.org/.
42. UniProt Consortium (2012) Reorganizing the protein space at the Universal Protein Resource (UniProt). Nucleic Acids Res 40: D71-75 doi:10.1093/nar/gkr981.
43. Wren JD, (2009) A global meta-analysis of microarray expression data to predict unknown gene functions and estimate the literature-data divide. Bioinformatics 25: 1694-1701 doi:10.1093/bioinformatics/btp290.
44. Oron A, Gentleman R, (n.d.) GSEAlm: Linear model toolset for Gene Set Enrichment Analysis. R project.
45. Tarca AL, Kathri P, Draghici S, (2011) SPIA: Signaling Pathway Impact Analysis (SPIA) using combined evidence of pathway over-representation and unusual signaling perturbations. R project Available:http://bioinformatics.oxfordjournals.org/cgi/reprint/btn577v1.
46. Huaiyu M, Thomas P, (2009) PANTHER Pathway: An Ontology-Based Pathway Database Coupled with Data Analysis Tools. Protein Networks and Pathway Analysis. Methods in Molecular Biology 563: 123-140.
47. David M, Chen HE, Goelz S, Larner AC, Neel BG, (1995) Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol 15: 7050-7058.
48. Suzuki H, Shibano K, Okane M, Kono I, Matsui Y, et al. (1989) Interferon-gamma modulates messenger RNA levels of c-sis (PDGF-B chain), PDGF-A chain, and IL-1 beta genes in human vascular endothelial cells. Am J Pathol 134: 35-43.
49. Gu Y, (1997) Activation of Interferon-gamma Inducing Factor Mediated by Interleukin-1beta Converting Enzyme. Science 275: 206-209 doi:10.1126/science.275.5297.206.
50. Hartman SE, (2005) Global changes in STAT target selection and transcription regulation upon interferon treatments. Genes & Development 19: 2953-2968 doi:10.1101/gad.1371305.
51. Krouwels FH, Hol BE, Lutter R, Bruinier B, Bast A, et al. (1998) Histamine affects interleukin-4, interleukin-5, and interferon-gamma production by human T cell clones from the airways and blood. Am J Respir Cell Mol Biol 18: 721-730.
52. Spencer TE, (1996) Ovine interferon tau suppresses transcription of the estrogen receptor and oxytocin receptor genes in the ovine endometrium. Endocrinology 137: 1144-1147 doi:10.1210/en.137.3.1144.
53. Valyasevi RW, (2001) Effect of Tumor Necrosis Factor-, Interferon-, and Transforming Growth Factor- on Adipogenesis and Expression of Thyrotropin Receptor in Human Orbital Preadipocyte Fibroblasts. Journal of Clinical Endocrinology & Metabolism 86: 903-908 doi:10.1210/jc.86.2.903.
54. Defilippi P, Truffa G, Stefanuto G, Altruda F, Silengo L, et al. (1991) Tumor necrosis factor alpha and interferon gamma modulate the expression of the vitronectin receptor (integrin beta 3) in human endothelial cells. J Biol Chem 266: 7638-7645.
55. Drapier J-C, Wietzerbin J, Hibbs JB, (1988) Interferon-γ and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages*. European Journal of Immunology 18: 1587-1592 doi:10.1002/eji.1830181018.
56. Araya J, Cambier S, Markovics JA, Wolters P, Jablons D, et al. (2007) Squamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patients. Journal of Clinical Investigation 117: 3551-3562 doi:10.1172/JCI32526.
57. Imaoka H, Hoshino T, Takei S, Kinoshita T, Okamoto M, et al. (2008) Interleukin-18 production and pulmonary function in COPD. Eur Respir J 31: 287-297 doi:10.1183/09031936.00019207.
58. Tsoumakidou M, Tzanakis N, Chrysofakis G, Siafakas NM, (2005) Nitrosative stress, heme oxygenase-1 expression and airway inflammation during severe exacerbations of COPD. Chest 127: 1911-1918 doi:10.1378/chest.127.6.1911.
59. Anderson D, Hughes JA, Cebulska-Wasilewska A, Nizankowska E, Graca B, (1998) Ras p21 protein levels in human plasma from patients with chronic obstructive pulmonary disease (COPD) compared with lung cancer patients and healthy controls. Mutat Res 403: 229-235.
60. Xiao W, Tong W, Ma D, (2006) [Higher levels of urokinase plasminogen activator system components in the airways of chronic obstructive pulmonary disease patients]. Zhonghua Jie He He Hu Xi Za Zhi 29: 723-726.
61. Esther CR Jr, Lazaar AL, Bordonali E, Qaqish B, Boucher RC, (2011) Elevated airway purines in COPD. Chest 140: 954-960 doi:10.1378/chest.10-2471.
62. Ottenheijm CAC, Heunks LMA, Li Y-P, Jin B, Minnaard R, et al. (2006) Activation of the ubiquitin-proteasome pathway in the diaphragm in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 174: 997-1002 doi:10.1164/rccm.200605-721OC.
63. Gosens R, Zaagsma J, Meurs H, Halayko AJ, (2006) Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir Res 7: 73 doi:10.1186/1465-9921-7-73.
64. Zhang J, Summah H, Zhu Y, Qu J-M, (2011) Nicotinic acetylcholine receptor variants associated with susceptibility to chronic obstructive pulmonary disease: a meta-analysis. Respiratory Research 12: 158 doi:10.1186/1465-9921-12-158.
65. Undas A, Kaczmarek P, Sladek K, Stepien E, Skucha W, et al. (2009) Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease. Beneficial effects of simvastatin treatment. Thromb Haemost 102: 1176-1182 doi:10.1160/TH09-02-0118.